Cargando…

Multidrug resistance genes screening of pancreatic ductal adenocarcinoma based on sensitivity profile to chemotherapeutic drugs

BACKGROUNDS: Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancer types and chemotherapeutic drug resistance is a stumbling block in improving the overall survival of PDAC patients. The nature of specific drug resistant subpopulation within pancreatic ductal adenocarcinoma is bel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Bangbo, Qin, Cheng, Li, Zeru, Wang, Yuanyang, Li, Tianhao, Cao, Hongtao, Yang, Xiaoying, Li, Tianyu, Wang, Weibin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714099/ https://www.ncbi.nlm.nih.gov/pubmed/36457017 http://dx.doi.org/10.1186/s12935-022-02785-7

Ejemplares similares

DHX38 restricts chemoresistance by regulating the alternative pre-mRNA splicing of RELL2 in pancreatic ductal adenocarcinoma
por: Li, Zeru, et al.
Publicado: (2023)

Long Noncoding RNA and Circular RNA: Two Rising Stars in Regulating Epithelial-Mesenchymal Transition of Pancreatic Cancer
por: Yang, Xiaoying, et al.
Publicado: (2022)

CHRNB2 represses pancreatic cancer migration and invasion via inhibiting β-catenin pathway
por: Qin, Cheng, et al.
Publicado: (2022)

Pancreatic cancer stemness: dynamic status in malignant progression
por: Zhao, Yutong, et al.
Publicado: (2023)

EGR1 induces EMT in pancreatic cancer via a P300/SNAI2 pathway
por: Wang, Yuanyang, et al.
Publicado: (2023)

STOML2 restricts mitophagy and increases chemosensitivity in pancreatic cancer through stabilizing PARL-induced PINK1 degradation
por: Qin, Cheng, et al.
Publicado: (2023)

Chromatin Dynamics in Digestive System Cancer: Commander and Regulator
por: Li, Zeru, et al.
Publicado: (2022)

Concerted cell and in vivo screen for pancreatic ductal adenocarcinoma (PDA) chemotherapeutics
por: Layeghi-Ghalehsoukhteh, Somayeh, et al.
Publicado: (2020)

Dynamic change of serum CA19–9 levels in benign and malignant patients with obstructive jaundice after biliary drainage and new correction formulas
por: Zhao, Bangbo, et al.
Publicado: (2021)

High aspartate aminotransferase to alanine aminotransferase ratio on admission as risk factor for poor prognosis in COVID-19 patients
por: Qin, Cheng, et al.
Publicado: (2020)

Conformation-Specific Inhibitory Anti-MMP-7 Monoclonal Antibody Sensitizes Pancreatic Ductal Adenocarcinoma Cells to Chemotherapeutic Cell Kill
por: Mohan, Vishnu, et al.
Publicado: (2021)

Distinguishing Coronavirus Disease 2019 Patients From General Surgery Emergency Patients With the CIAAD Scale: Development and Validation of a Prediction Model Based on 822 Cases in China
por: Zhao, Bangbo, et al.
Publicado: (2021)

Clinical characteristics and prognostic factors of Hurthle cell carcinoma: a population based study
por: Zhou, Xingtong, et al.
Publicado: (2020)

Targeting BPTF Sensitizes Pancreatic Ductal Adenocarcinoma to Chemotherapy by Repressing ABC-Transporters and Impairing Multidrug Resistance (MDR)
por: Muñoz Velasco, Raúl, et al.
Publicado: (2022)

Establishment of organoid models for pancreatic ductal adenocarcinoma and screening of individualized therapy strategy
por: Gong, Miaomiao, et al.
Publicado: (2023)

Metabolism remodeling in pancreatic ductal adenocarcinoma
por: Li, Jin-Tao, et al.
Publicado: (2019)

Microarray expression profile of circular RNAs in human pancreatic ductal adenocarcinoma
por: Qu, Shibin, et al.
Publicado: (2015)

Interventional Nanotheranostics of Pancreatic Ductal Adenocarcinoma
por: Li, Junjie, et al.
Publicado: (2016)

Oral mycobiota and pancreatic ductal adenocarcinoma
por: Wei, Ailin, et al.
Publicado: (2022)

Evening Primrose Oil Improves Chemotherapeutic Effects in Human Pancreatic Ductal Adenocarcinoma Cell Lines—A Preclinical Study
por: Zeppa, Laura, et al.
Publicado: (2022)

The immune escape signature predicts the prognosis and immunotherapy sensitivity for pancreatic ductal adenocarcinoma
por: Lu, Hao, et al.
Publicado: (2022)

A rapid in vivo screen for pancreatic ductal adenocarcinoma therapeutics
por: Ocal, Ozhan, et al.
Publicado: (2015)

Crosstalk Between Peripheral Innervation and Pancreatic Ductal Adenocarcinoma
por: Ni, Bo, et al.
Publicado: (2023)

Mimics of pancreatic ductal adenocarcinoma
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Pancreatic ductal adenocarcinoma staging
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Syndecans and Pancreatic Ductal Adenocarcinoma
por: Betriu, Nausika, et al.
Publicado: (2021)

Models of pancreatic ductal adenocarcinoma
por: Dennaoui, Rayane, et al.
Publicado: (2021)

Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma
por: Tong, Yexin, et al.
Publicado: (2022)

Prognostic Biomarkers for Pancreatic Ductal Adenocarcinoma: An Umbrella Review
por: Wang, Yizhi, et al.
Publicado: (2020)

BAG3‐positive pancreatic stellate cells promote migration and invasion of pancreatic ductal adenocarcinoma
por: Yuan, Ye, et al.
Publicado: (2019)

Pancreatic Ductal Adenocarcinoma Associated with Autoimmune Pancreatitis
por: Pezzilli, Raffaele, et al.
Publicado: (2011)

Overexpression of Mesothelin in Pancreatic Ductal Adenocarcinoma (PDAC)
por: Le, Kai, et al.
Publicado: (2020)

Use of DNA‐alkylating pyrrole‐imidazole polyamides for anti‐cancer drug sensitivity screening in pancreatic ductal adenocarcinoma
por: Tsujimoto, Akiko, et al.
Publicado: (2022)

Inhibition of DCLK1 kinase reverses epithelial-mesenchymal transition and restores T-cell activity in pancreatic ductal adenocarcinoma
por: Ge, Yang, et al.
Publicado: (2022)

Pancreatic ductal adenocarcinoma immune microenvironment and immunotherapy prospects
por: Li, Ke-Yu, et al.
Publicado: (2020)

Untargeted metabolomics characterization of the resectable pancreatic ductal adenocarcinoma
por: Cao, Ying-Ying, et al.
Publicado: (2023)

Molecular drivers and cells of origin in pancreatic ductal adenocarcinoma and pancreatic neuroendocrine carcinoma
por: Gao, He-Li, et al.
Publicado: (2020)

Reg proteins promote acinar-to-ductal metaplasia and act as novel diagnostic and prognostic markers in pancreatic ductal adenocarcinoma
por: Li, Qing, et al.
Publicado: (2016)

The fecal microbiota of patients with pancreatic ductal adenocarcinoma and autoimmune pancreatitis characterized by metagenomic sequencing
por: Zhou, Wenli, et al.
Publicado: (2021)

Lin28B facilitates the progression and metastasis of pancreatic ductal adenocarcinoma
por: Wang, Yunchao, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lnn7rbnp8pnb13fu2rdrceo5l7